MP25-20 EFFECT OF CHANGES IN SKELETAL MUSCLE MASS ON ONCOLOGICAL OUTCOMES DURING FIRST-LINE SUNITINIB THERAPY FOR METASTATIC RENAL CELL CARCINOMA
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.